Correlations between physician-perceived functional status, patient-perceived health status, and cardiopulmonary exercise results in hypertrophic cardiomyopathy

Quality of Life Research

Volumn 22, Issue 3, 2013, Pages 647-652

  Huff, Christopher M ^a   Turer, Aslan T ^b   Wang, Andrew ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Exercise test; Hypertrophic cardiomyopathy; NYHA; Quality of life; Questionnaire

Indexed keywords

AGED; CARDIOMYOPATHY, HYPERTROPHIC; COMPLICATION; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HEART FAILURE; HEART STROKE VOLUME; HUMAN; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PERCEPTION; PREDICTIVE VALUE; PROCEDURES; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VERY ELDERLY; ARTICLE; HYPERTROPHIC CARDIOMYOPATHY; METHODOLOGY; PSYCHOLOGICAL ASPECT;

AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEALTH STATUS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PERCEPTION; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TREATMENT OUTCOME;

EID: 84876470847     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-012-0182-y     Document Type: Article

References (17)

1. Maron, B. J., Casey, S. A., Poliac, L. C., Gohman, T. E., Almquist, A. K., & Aeppli, D. M. (1999). Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA, 281(7), 650-655.
2. Maron, B. J., McKenna, W. J., Danielson, G. K., et al. (2003). American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Journal of the American College of Cardiology, 42(9), 1687-1713.
3. Green, C. P., Porter, C. B., Bresnahan, D. R., & Spertus, J. A. (2000). Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. Journal of the American College of Cardiology, 35(5), 1245-1255.
4. Balady, G. J., Arena, R., Sietsema, K., et al. (2010). Clinician's Guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association. Circulation, 122(2), 191-225.
5. Sharma, S., Elliott, P., Whyte, G., et al. (2000). Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. American Journal of Cardiology, 86(2), 162-168.
6. Jones, S., Elliott, P. M., Sharma, S., McKenna, W. J., & Whipp, B. J. (1998). Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy. Heart, 80(1), 60-67.
7. Eurich, D. T., Johnson, J. A., Reid, K. J., & Spertus, J. A. (2006). Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Quality of Life Outcomes, 4, 89.
8. Spertus, J., Peterson, E., Conard, M. W., et al. (2005). Monitoring clinical changes in patients with heart failure: A comparison of methods. American Heart Journal, 150(4), 707-715.
9. Wasserman, K., Hansen, J. E., Sue, D. Y., Stringer, W., & Whipp, B. J. (2005). Normal values. In: R. Weinberg (Ed.), Principles of exercise testing and interpretation (pp. 160-182, 4th ed.). Philadelphia, Pa: Lippincott Williams and Wilkins.
10. Arena, R., Myers, J., Aslam, S. S., Varughese, E. B., & Peberdy, M. A. (2004). Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. American Heart Journal, 147(2), 354-360.
11. Cox, S., O'Donoghue, A. C., McKenna, W. J., & Steptoe, A. (1997). Health related quality of life and psychological wellbeing in patients with hypertrophic cardiomyopathy. Heart, 78(2), 182-187.
12. Nishimura, R. A., Trusty, J. M., Hayes, D. L., et al. (1997). Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial. Journal of the American College of Cardiology, 29(2), 435-441.
13. Boekstegers, P., Steinbigler, P., Molnar, A., et al. (2001). Pressure-guided nonsurgical myocardial reduction induced by small septal infarctions in hypertrophic obstructive cardiomyopathy. Journal of the American College of Cardiology, 38(3), 846-853.
14. Flynn, K. E., Pina, I. L., Whellan, D. J., et al. (2009). Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA, 301(14), 1451-1459.
15. Nagueh, S. F., Groves, B. M., Schwartz, L., et al. (2011). Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. Journal of the American College of Cardiology, 58(22), 2322-2328.
16. Gersh, B. J., Maron, B. J., Bonow, R. O., et al. (2011). 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 124(24), 2761-2796.
17. Goldman, L., Cook, E. F., Mitchell, N., Flatley, M., Sherman, H., & Cohn, P. F. (1982). Pitfalls in the serial assessment of cardiac functional status. How a reduction in "ordinary" activity may reduce the apparent degree of cardiac compromise and give a misleading impression of improvement. Journal of Chronic Diseases, 35(10), 763-771.